United States · FDA National Drug Code directory
Zepbound
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-6523_a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fc
- Product NDC
- 0002-6523
- Form
- INJECTION, SOLUTION
- Composition / generic term
- tirzepatide
- Labeler
- Eli Lilly and Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260107
- Source listing expiry
- 20271231
Source-listed ingredients
- TIRZEPATIDE — 20.8 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6523-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-6523-01) · 0002-6523-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →